Cargando…
Retrospective Analysis of Eculizumab in Patients with Acetylcholine Receptor Antibody-Negative Myasthenia Gravis: A Case Series
BACKGROUND: The role of the complement cascade in acetylcholine receptor antibody-negative (AChR–) myasthenia gravis (MG) is unclear. OBJECTIVE: To assess the efficacy and tolerability of eculizumab (terminal complement inhibitor) in patients with AChR–MG. METHODS: Retrospective chart review of data...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369065/ https://www.ncbi.nlm.nih.gov/pubmed/32444555 http://dx.doi.org/10.3233/JND-190464 |